✦ LIBER ✦

Risk of intracranial haemorrhage in patients with atrial fibrillation treated with novel oral anticoagulants: testing the equivalence margins between dabigratran, rivaroxaban and apixaban

✍ Scribed by Messori, Andrea; Maratea, Dario; Fadda, Valeria; Trippoli, Sabrina

Book ID: 125342585
Publisher: Springer
Year: 2014
Tongue: English
Weight: 275 KB
Volume: 70
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-014-1644-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracranial Hemorrhage Among Patients W

Intracranial Hemorrhage Among Patients With Atrial Fibrillation Anticoagulated With Warfarin or Rivaroxaban: The Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

✍ Hankey, G. J.; Stevens, S. R.; Piccini, J. P.; Lokhnygina, Y.; Mahaffey, K. W.; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 920 KB

The interval between prothrombin time te

The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation

✍ Varda Shalev; Ori Rogowski; Orit Shimron; Bracha Sheinberg; Itzhak Shapira; Uri 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 344 KB

Letter by Apostolakis et al Regarding Ar

Letter by Apostolakis et al Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R 2 CHADS 2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

✍ Apostolakis, Stavros ;Lane, Deirdre A. ;Banerjee, Amitava 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 419 KB